医疗机构将于2024年10月24日发布第一季度财务业绩,并进行网络广播讨论. ResMed releases Q1 FY2025 financial results on Oct 24, 2024, with a webcast discussion.

瑞思迈将于 2024 年 10 月 24 日纽约证券交易所收盘后发布其 2025 财年第一季度财务业绩，随后将进行网络直播讨论。 ResMed will release its Q1 fiscal year 2025 financial results on October 24, 2024, after NYSE closes, with a webcast discussion to follow. 活动将在他们的网站上进行,此后可重播。 The event will be accessible on their website, with a replay available afterward. 该公司侧重于针对睡眠性脑膜炎和慢性疾病的创新解决方案,旨在通过2030年战略实现长期增长,其中包括加强产品开发,利用AI改善治疗。 The company focuses on innovative solutions for sleep apnea and chronic diseases, aiming for long-term growth through its 2030 strategy, which includes enhancing product development and leveraging AI for improved therapies.